Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis

Mona Gandhi, Eihab Alwawi, Kenneth B. Gordon*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

45 Scopus citations

Fingerprint Dive into the research topics of 'Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis'. Together they form a unique fingerprint.

Medicine & Life Sciences